22-June-2024 : Keeping It Simple with Price Action & Technical Analysis.
This stock showed up in my screener, and liked the chart and price action.
Putting out my analysis objectively using Point & Figure.
** I do not own this stock, and my analysis may have mistakes and incorrect. So please DYOR and always use a Stop/Loss..
* Using P & F with a box size of 0.15 on a Daily chart.
* The stock has been in a long term uptrend.
* After making a breakout in Oct'2023 ( shown by the long "X" Anchor column), the stock went into consolidation and on 21-Jun-2024, we saw creation of a fresh "X" column signalling a "probable" resumption of its uptrend. This will be confirmed once it does a double top buy around the ORANGE zone immediately above it.
* If it crosses the Orange zone, and remains above the BLUE line, then I am forecasting an immediate price target of around 16, based on the open Anchor Column count. [ If we see behind, then the last target anchor count has already been met ].
LYL
lycopodium limited
Add to My Watchlist
2.04%
!
$12.50

ASXCharts - LYL - Technical Analysis
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.50 |
Change
0.250(2.04%) |
Mkt cap ! $496.7M |
Open | High | Low | Value | Volume |
$12.27 | $12.72 | $12.18 | $822.4K | 66.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6417 | $12.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.50 | 1484 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 12.300 |
1 | 2039 | 12.260 |
1 | 500 | 12.190 |
1 | 464 | 12.180 |
1 | 1238 | 12.100 |
Price($) | Vol. | No. |
---|---|---|
12.500 | 1484 | 1 |
12.510 | 500 | 1 |
12.540 | 100 | 1 |
12.600 | 95 | 1 |
12.670 | 79 | 1 |
Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
Featured News
LYL (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online